Incorporating Incretin-Based Therapies Into Clinical Practice for Patients With Type 2 Diabetes

Advances in Therapy - United States
doi 10.1007/s12325-014-0100-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Comparison of Efficacy Between Incretin-Based Therapies for Type 2 Diabetes Mellitus

BMC Medicine
Medicine
2012English

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Cardiovascular Effects of Incretin-Based Therapies in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Effect of Long-Term Incretin-Based Therapies on Ischemic Heart Diseases in Patients With Type 2 Diabetes Mellitus: A Network Meta-Analysis

Scientific Reports
Multidisciplinary
2017English

Erratum To: Pharmacokinetics in Patients With Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus

Clinical Pharmacokinetics
Pharmacology
2014English

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Erratum: Incretin Mimetics Vie for Slice of Type 2 Diabetes Market

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy